Roxana Mehran, MD, is a prolific researcher at the Icahn School of Medicine at Mount Sinai. Talk begins at: [ Ссылка ]
Objectives:
1. Understanding the importance of bleeding post PCI.
2. To determine the impact of SAPT (ticagrelor monotherapy) vs. DAPT (ticagrelor + aspirin) for 12 months in reducing clinically relevant bleeding among high-risk patients who have undergone successful PCI.
3. To determine the impact of SAPT (ticagrelor monotherapy) vs. DAPT (ticagrelor + aspirin) for 12 months on major ischemic adverse event among high-risk patients who have undergone successful PCI.
Follow Yale Cardiovascular Medicine on Twitter: [ Ссылка ]
Sign up for email updates: [ Ссылка ]
